See how company executives and directors have been buying or selling shares over the past 30 days. Insider trading activity can help investors better understand company leadership's actions.
No Insider Transactions found for CytomX Therapeutics, Inc.
Browse insider buying and selling activity reported to the SEC over the past year, including who traded, when they traded, and the value of each transaction.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Jun 15, 2026 Ogden Christopher |
Ogden Christopher
CFO
|
Sell |
1,624 | $3.05 | 1,624 $3.05 $4,953 |
Mar 17, 2026 McCarthy Sean A. |
McCarthy Sean A.
CEO
|
Sell |
118,969 | $6.42 | 118,969 $6.42 $764,138 |
Mar 17, 2026 Chu Yu-Waye |
Chu Yu-Waye
CMO
|
Sell |
21,279 | $6.42 | 21,279 $6.42 $136,675 |
Mar 17, 2026 Ogden Christopher |
Ogden Christopher
CFO
|
Sell |
19,323 | $6.42 | 19,323 $6.42 $124,112 |
Mar 17, 2026 BELVIN MARCIA |
BELVIN MARCIA
SVP, Chief Scientific Officer
|
Sell |
31,492 | $6.42 | 31,492 $6.42 $202,273 |
View older insider trading records reported to the SEC to research long-term buying and selling trends.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Nov 06, 2025 McCarthy Sean A. |
McCarthy Sean A.
CEO
|
Sell |
101,793 | $4.54 | 101,793 $4.54 $461,906 |
Jun 16, 2025 McCarthy Sean A. |
McCarthy Sean A.
CEO
|
Sell |
55,511 | $2.69 | 55,511 $2.69 $149,264 |
Jun 16, 2025 Ogden Christopher |
Ogden Christopher
CFO
|
Sell |
10,614 | $2.69 | 10,614 $2.69 $28,540 |
Jun 16, 2025 BELVIN MARCIA |
BELVIN MARCIA
SVP, Chief Scientific Officer
|
Sell |
13,884 | $2.69 | 13,884 $2.69 $37,334 |
Jun 13, 2025 Ogden Christopher |
Ogden Christopher
CFO
|
Sell |
1,641 | $2.95 | 1,641 $2.95 $4,841 |
Mar 18, 2025 McCarthy Sean A. |
McCarthy Sean A.
CEO
|
Sell |
37,656 | $0.60 | 37,656 $0.60 $22,556 |
Mar 18, 2025 Chu Yu-Waye |
Chu Yu-Waye
CMO
|
Sell |
4,025 | $0.60 | 4,025 $0.60 $2,411 |
Mar 18, 2025 ROWLAND LLOYD A |
ROWLAND LLOYD A
General Counsel
|
Sell |
10,203 | $0.60 | 10,203 $0.60 $6,112 |
Mar 18, 2025 Ogden Christopher |
Ogden Christopher
CFO
|
Sell |
8,551 | $0.60 | 8,551 $0.60 $5,122 |
Mar 18, 2025 BELVIN MARCIA |
BELVIN MARCIA
SVP, Chief Scientific Officer
|
Sell |
19,512 | $0.60 | 19,512 $0.60 $11,688 |
Aug 20, 2024 BELVIN MARCIA |
BELVIN MARCIA
SVP, Chief Scientific Officer
|
Sell |
4,181 | $1.23 | 4,181 $1.23 $5,139 |
Aug 20, 2024 Landau Jeffrey B |
Landau Jeffrey B
CBO
|
Sell |
4,181 | $1.23 | 4,181 $1.23 $5,139 |
Aug 20, 2024 ROWLAND LLOYD A |
ROWLAND LLOYD A
General Counsel
|
Sell |
4,181 | $1.23 | 4,181 $1.23 $5,139 |
Aug 20, 2024 Ogden Christopher |
Ogden Christopher
CFO
|
Sell |
1,984 | $1.23 | 1,984 $1.23 $2,439 |
Aug 20, 2024 McCarthy Sean A. |
McCarthy Sean A.
CEO
|
Sell |
13,898 | $1.23 | 13,898 $1.23 $17,082 |
Mar 19, 2024 Landau Jeffrey B |
Landau Jeffrey B
CBO
|
Sell |
6,562 | $2.09 | 6,562 $2.09 $13,685 |
Mar 19, 2024 McCarthy Sean A. |
McCarthy Sean A.
CEO
|
Sell |
20,223 | $2.09 | 20,223 $2.09 $42,175 |
Mar 19, 2024 ROWLAND LLOYD A |
ROWLAND LLOYD A
General Counsel
|
Sell |
5,268 | $2.09 | 5,268 $2.09 $10,986 |
Mar 19, 2024 Ogden Christopher |
Ogden Christopher
SVP, FINANCE AND ACCOUNTING
|
Sell |
2,971 | $2.09 | 2,971 $2.09 $6,196 |
Mar 19, 2024 BELVIN MARCIA |
BELVIN MARCIA
SVP, Chief Scientific Officer
|
Sell |
12,795 | $2.09 | 12,795 $2.09 $26,684 |
TOP
